| scholarly article | Q13442814 |
| P2093 | author name string | Don Ganem | |
| Mihaela Skobe | |||
| Simona Podgrabinska | |||
| Claudia Grossmann | |||
| P2860 | cites work | Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes | Q24339405 |
| Kaposi's sarcoma associated herpes virus-encoded viral FLICE inhibitory protein activates transcription from HIV-1 Long Terminal Repeat via the classical NF-kappaB pathway and functionally cooperates with Tat | Q24800209 | ||
| Modulation of the NF-kappa B pathway by virally encoded death effector domains-containing proteins | Q28145950 | ||
| Deregulation of NF-kappaB and its upstream kinases in cancer | Q28190190 | ||
| Activation of interleukin-6 gene expression through the NF-kappa B transcription factor | Q28646310 | ||
| NF-kappaB at the crossroads of life and death | Q29619302 | ||
| Activation of Rac1 by shear stress in endothelial cells mediates both cytoskeletal reorganization and effects on gene expression. | Q30453215 | ||
| Expression of vascular endothelial growth factor receptor-3 and podoplanin suggests a lymphatic endothelial cell origin of Kaposi's sarcoma tumor cells. | Q30653484 | ||
| Characterization of the promoter for vascular cell adhesion molecule-1 (VCAM-1) | Q30990350 | ||
| Spindle cell conversion by Kaposi's sarcoma-associated herpesvirus: formation of colonies and plaques with mixed lytic and latent gene expression in infected primary dermal microvascular endothelial cell cultures | Q33841987 | ||
| Molecular characterization of lymphatic endothelial cells. | Q34415420 | ||
| The Human Herpes Virus 8-Encoded Viral FLICE-inhibitory Protein Induces Cellular Transformation via NF-κB Activation | Q34542601 | ||
| Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma. | Q34548882 | ||
| Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Induces Expression of the Helix-Loop-Helix Protein Id-1 in Human Endothelial Cells | Q34976840 | ||
| Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma | Q35131811 | ||
| NF-kappaB inhibits gammaherpesvirus lytic replication | Q35155154 | ||
| Activation of alternative NF-kappa B pathway by human herpes virus 8-encoded Fas-associated death domain-like IL-1 beta-converting enzyme inhibitory protein (vFLIP). | Q35319917 | ||
| The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors | Q36375370 | ||
| KSHV vFLIP is essential for the survival of infected lymphoma cells | Q36399405 | ||
| Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors | Q36852093 | ||
| AIDS, Kaposi sarcoma, and the lymphatic system: update and reflections. | Q37965529 | ||
| NF-kappa B as inducible transcriptional activator of the granulocyte-macrophage colony-stimulating factor gene | Q38341645 | ||
| Nuclear factor-kappa B potently up-regulates the promoter activity of RANTES, a chemokine that blocks HIV infection. | Q39269743 | ||
| Limited transmission of Kaposi's sarcoma-associated herpesvirus in cultured cells | Q39580911 | ||
| De novo infection and serial transmission of Kaposi's sarcoma-associated herpesvirus in cultured endothelial cells | Q39748116 | ||
| Host Range of Kaposi's Sarcoma-Associated Herpesvirus in Cultured Cells | Q39752549 | ||
| Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells | Q39877852 | ||
| Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis. | Q40364647 | ||
| The human herpes virus 8-encoded viral FLICE inhibitory protein protects against growth factor withdrawal-induced apoptosis via NF-kappa B activation | Q40693631 | ||
| The human herpes virus 8-encoded viral FLICE inhibitory protein physically associates with and persistently activates the Ikappa B kinase complex | Q40752466 | ||
| Human herpesvirus 8 viral FLICE-inhibitory protein inhibits Fas-mediated apoptosis through binding and prevention of procaspase-8 maturation. | Q40794971 | ||
| Kaposi's sarcoma-associated herpesvirus induction of chromosome instability in primary human endothelial cells | Q42328529 | ||
| Microtubule disruption utilizes an NFkappa B-dependent pathway to stabilize HIF-1alpha protein | Q44253539 | ||
| KSHV vFLIP binds to IKK-gamma to activate IKK. | Q44532483 | ||
| Identification and culture of Kaposi's sarcoma-like spindle cells from the peripheral blood of human immunodeficiency virus-1-infected individuals and normal controls | Q45789684 | ||
| Fluid shear stress activation of IkappaB kinase is integrin-dependent | Q46721477 | ||
| Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus | Q47675996 | ||
| Kaposi's sarcoma cells: long-term culture with growth factor from retrovirus-infected CD4+ T cells. | Q52833089 | ||
| Angiogenic properties of Kaposi's sarcoma-derived cells after long-term culture in vitro. | Q55242415 | ||
| Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma–associated herpesvirus | Q56794246 | ||
| Vascular Endothelial Growth Factor-C (VEGF-C) and its Receptors KDR and flt-4 are Expressed in AIDS-Associated Kaposi’s Sarcoma | Q57382283 | ||
| Shear Stress-Induced Cytoskeleton Rearrangement Mediates NF-κB-Dependent Endothelial Expression of ICAM-1 | Q57703713 | ||
| Kaposi's sarcoma: a result of the interplay among inflammatory cytokines, angiogenic factors and viral agents | Q61641140 | ||
| Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells | Q71563744 | ||
| Kaposi's sarcoma-associated herpesvirus encoded vFLIP induces cellular IL-6 expression: the role of the NF-kappaB and JNK/AP1 pathways | Q73456324 | ||
| Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo | Q73596145 | ||
| Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3 | Q74489252 | ||
| P433 | issue | 14 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| NF-κB | Q411114 | ||
| P304 | page(s) | 7179-7185 | |
| P577 | publication date | 2006-07-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Activation of NF-kappaB by the latent vFLIP gene of Kaposi's sarcoma-associated herpesvirus is required for the spindle shape of virus-infected endothelial cells and contributes to their proinflammatory phenotype | |
| P478 | volume | 80 |
| Q34280032 | A computational profiling of changes in gene expression and transcription factors induced by vFLIP K13 in primary effusion lymphoma |
| Q44120684 | A nuclear role for Kaposi's sarcoma-associated herpesvirus-encoded K13 protein in gene regulation. |
| Q42624833 | A unique herpesviral transcriptional program in KSHV-infected lymphatic endothelial cells leads to mTORC1 activation and rapamycin sensitivity |
| Q35065227 | A20 is induced by Kaposi sarcoma-associated herpesvirus-encoded viral FLICE inhibitory protein (vFLIP) K13 and blocks K13-induced nuclear factor-kappaB in a negative feedback manner |
| Q36673788 | A20/TNFAIP3 inhibits NF-κB activation induced by the Kaposi's sarcoma-associated herpesvirus vFLIP oncoprotein |
| Q36691805 | Adult human sarcomas. I. Basic science |
| Q39729318 | Array-based transcript profiling and limiting-dilution reverse transcription-PCR analysis identify additional latent genes in Kaposi's sarcoma-associated herpesvirus |
| Q41840182 | COX-2/PGE2: molecular ambassadors of Kaposi's sarcoma-associated herpes virus oncoprotein-v-FLIP. |
| Q36373882 | Characterization of c-Kit expression and activation in KSHV-infected endothelial cells |
| Q34303583 | Contribution of viral mimics of cellular genes to KSHV infection and disease. |
| Q38097263 | Cyclooxygenase-2-prostaglandin E2-eicosanoid receptor inflammatory axis: a key player in Kaposi's sarcoma-associated herpes virus associated malignancies |
| Q38748567 | Deletion of Kaposi's sarcoma-associated herpesvirus FLICE inhibitory protein, vFLIP, from the viral genome compromises the activation of STAT1-responsive cellular genes and spindle cell formation in endothelial cells |
| Q36755072 | Distinct Activation Mechanisms of NF-κB Regulator Inhibitor of NF-κB Kinase (IKK) by Isoforms of the Cell Death Regulator Cellular FLICE-like Inhibitory Protein (cFLIP). |
| Q42131073 | Effects of NFkappaB activation on KSHV latency and lytic reactivation are complex and context-dependent |
| Q36404184 | Emerging themes from EBV and KSHV microRNA targets |
| Q38111863 | Evasion of adaptive and innate immune response mechanisms by γ-herpesviruses |
| Q35090908 | Expanding the role of Drosha to the regulation of viral gene expression |
| Q37099734 | Gene regulation and functional alterations induced by Kaposi's sarcoma-associated herpesvirus-encoded ORFK13/vFLIP in endothelial cells |
| Q47290411 | Generation of a KSHV K13 deletion mutant for vFLIP function study. |
| Q40174372 | HIV-associated Kaposi sarcoma and related diseases. |
| Q37888397 | Human herpesvirus 8-associated neoplasms: the roles of viral replication and antiviral treatment. |
| Q34614394 | Human tumor-associated viruses and new insights into the molecular mechanisms of cancer |
| Q37711147 | Human viral oncogenesis: a cancer hallmarks analysis |
| Q34795543 | Immune Evasion by Kaposi‘s Sarcoma-Associated Herpesvirus |
| Q37307209 | Immune evasion in Kaposi's sarcoma-associated herpes virus associated oncogenesis |
| Q37209090 | Induction of CCL20 production by Kaposi sarcoma-associated herpesvirus: role of viral FLICE inhibitory protein K13-induced NF-kappaB activation |
| Q35758587 | Inefficient Codon Usage Impairs mRNA Accumulation: the Case of the v-FLIP Gene of Kaposi's Sarcoma-Associated Herpesvirus |
| Q38048861 | Instigation of Notch signaling in the pathogenesis of Kaposi's sarcoma-associated herpesvirus and other human tumor viruses |
| Q33491306 | Integrated microarray and multiplex cytokine analyses of Kaposi's Sarcoma Associated Herpesvirus viral FLICE Inhibitory Protein K13 affected genes and cytokines in human blood vascular endothelial cells |
| Q35376259 | Interactions between Hsp90 and oncogenic viruses: implications for viral cancer therapeutics |
| Q90244925 | Interleukin-1 Receptor Associated Kinase (IRAK) signaling in Kaposi Sarcoma-associated herpesvirus (KSHV) induced Primary Effusion Lymphoma |
| Q34615002 | Interplay between Kaposi's sarcoma-associated herpesvirus and the innate immune system |
| Q28080198 | Interplay of Murine Gammaherpesvirus 68 with NF-kappaB Signaling of the Host |
| Q33303677 | K13 blocks KSHV lytic replication and deregulates vIL6 and hIL6 expression: a model of lytic replication induced clonal selection in viral oncogenesis |
| Q33761091 | KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine |
| Q38418556 | KSHV downregulation of galectin-3 in Kaposi's sarcoma |
| Q39033882 | KSHV strategies for host dsDNA sensing machinery |
| Q33955300 | KSHV vCyclin counters the senescence/G1 arrest response triggered by NF-κB hyperactivation |
| Q26742030 | KSHV-Mediated Angiogenesis in Tumor Progression |
| Q33627013 | KSHV-induced notch components render endothelial and mural cell characteristics and cell survival |
| Q36731435 | Kaposi sarcoma as a model of oncogenesis and cancer treatment. |
| Q40046587 | Kaposi sarcoma herpesvirus pathogenesis. |
| Q38962850 | Kaposi sarcoma herpesvirus-associated cancers and related diseases |
| Q34616590 | Kaposi sarcoma-associated herpesvirus-encoded viral FLICE inhibitory protein (vFLIP) K13 cooperates with Myc to promote lymphoma in mice |
| Q36487309 | Kaposi's sarcoma and its associated herpesvirus |
| Q34426472 | Kaposi's sarcoma herpesvirus K15 protein contributes to virus-induced angiogenesis by recruiting PLCγ1 and activating NFAT1-dependent RCAN1 expression |
| Q40114329 | Kaposi's sarcoma-associated herpesvirus (KSHV) oncoprotein K13 bypasses TRAFs and directly interacts with the IkappaB kinase complex to selectively activate NF-kappaB without JNK activation |
| Q39860632 | Kaposi's sarcoma-associated herpesvirus RTA promotes degradation of the Hey1 repressor protein through the ubiquitin proteasome pathway |
| Q40173444 | Kaposi's sarcoma-associated herpesvirus induces sustained NF-kappaB activation during de novo infection of primary human dermal microvascular endothelial cells that is essential for viral gene expression |
| Q39792755 | Kaposi's sarcoma-associated herpesvirus latency in endothelial and B cells activates gamma interferon-inducible protein 16-mediated inflammasomes. |
| Q36540187 | Kaposi's sarcoma-associated herpesvirus latent gene vFLIP inhibits viral lytic replication through NF-kappaB-mediated suppression of the AP-1 pathway: a novel mechanism of virus control of latency |
| Q36506932 | Kaposi's sarcoma-associated herpesvirus suppression of DUSP1 facilitates cellular pathogenesis following de novo infection. |
| Q33753956 | Kaposi's sarcoma-associated herpesvirus-encoded viral FLICE inhibitory protein (vFLIP) K13 suppresses CXCR4 expression by upregulating miR-146a |
| Q35801076 | Modulation of Immune System by Kaposi's Sarcoma-Associated Herpesvirus: Lessons from Viral Evasion Strategies |
| Q92989829 | Modulation of Innate Immune Signaling Pathways by Herpesviruses |
| Q34013830 | Molecular biology of human herpesvirus 8: novel functions and virus-host interactions implicated in viral pathogenesis and replication |
| Q24650331 | Molecular mechanism of BST2/tetherin downregulation by K5/MIR2 of Kaposi's sarcoma-associated herpesvirus |
| Q28544735 | NEDDylation is essential for Kaposi's sarcoma-associated herpesvirus latency and lytic reactivation and represents a novel anti-KSHV target |
| Q33887749 | NEMO is essential for Kaposi's sarcoma-associated herpesvirus-encoded vFLIP K13-induced gene expression and protection against death receptor-induced cell death, and its N-terminal 251 residues are sufficient for this process. |
| Q37192183 | NF-kappaB p50 plays distinct roles in the establishment and control of murine gammaherpesvirus 68 latency |
| Q37157187 | NF-kappaB serves as a cellular sensor of Kaposi's sarcoma-associated herpesvirus latency and negatively regulates K-Rta by antagonizing the RBP-Jkappa coactivator. |
| Q35571982 | Novel functions of viral anti-apoptotic factors |
| Q40641957 | Nuclear factor kappa B pathway associated biomarkers in AIDS defining malignancies. |
| Q40031635 | Opposing roles of RNA receptors TLR3 and RIG-I in the inflammatory response to double-stranded RNA in a Kaposi's sarcoma cell line |
| Q33432690 | Pre-micro RNA signatures delineate stages of endothelial cell transformation in Kaposi sarcoma. |
| Q30374718 | Probing the Solution Structure of IκB Kinase (IKK) Subunit γ and Its Interaction with Kaposi Sarcoma-associated Herpes Virus Flice-interacting Protein and IKK Subunit β by EPR Spectroscopy |
| Q37590325 | Regulation of angiogenesis in malignancies associated with Epstein-Barr virus and Kaposi's sarcoma-associated herpes virus |
| Q91168794 | Suppression of the SAP18/HDAC1 complex by targeting TRIM56 and Nanog is essential for oncogenic viral FLICE-inhibitory protein-induced acetylation of p65/RelA, NF-κB activation, and promotion of cell invasion and angiogenesis |
| Q40075465 | Synergistic activation of interferon-beta gene transcription by the viral FLICE inhibitory protein of Kaposi's sarcoma-associated herpesvirus and type I IFN activators |
| Q35546590 | Systemic expression of Kaposi sarcoma herpesvirus (KSHV) Vflip in endothelial cells leads to a profound proinflammatory phenotype and myeloid lineage remodeling in vivo |
| Q30408885 | Targeting sphingosine kinase induces apoptosis and tumor regression for KSHV-associated primary effusion lymphoma. |
| Q41932132 | The Kaposi's sarcoma-associated herpesvirus (KSHV) non-structural membrane protein K15 is required for viral lytic replication and may represent a therapeutic target. |
| Q37288834 | The inflammatory kinase MAP4K4 promotes reactivation of Kaposi's sarcoma herpesvirus and enhances the invasiveness of infected endothelial cells |
| Q38248404 | The role of Kaposi sarcoma-associated herpesvirus in the pathogenesis of Kaposi sarcoma |
| Q24685892 | The viral etiology of AIDS-associated malignancies |
| Q64247511 | Towards Better Understanding of KSHV Life Cycle: from Transcription and Posttranscriptional Regulations to Pathogenesis |
| Q54216669 | Transactivation of human endogenous retrovirus K (HERV-K) by KSHV promotes Kaposi's sarcoma development. |
| Q38256387 | Utilising proteomic approaches to understand oncogenic human herpesviruses (Review). |
| Q55618701 | VEGF Upregulation in Viral Infections and Its Possible Therapeutic Implications. |
| Q28543000 | Viral activation of MK2-hsp27-p115RhoGEF-RhoA signaling axis causes cytoskeletal rearrangements, p-body disruption and ARE-mRNA stabilization |
| Q41204341 | Viral activation of stress-regulated Rho-GTPase signaling pathway disrupts sites of mRNA degradation to influence cellular gene expression. |
| Q37033342 | Viral inhibitor of apoptosis vFLIP/K13 protects endothelial cells against superoxide-induced cell death. |
| Q34039189 | Viral latency and its regulation: lessons from the gamma-herpesviruses |
| Q42251926 | YGLF motif in the Kaposi sarcoma herpes virus G-protein-coupled receptor adjusts NF-κB activation and paracrine actions |
Search more.